Results 11 to 20 of about 5,904 (237)

Caffeine Treatment for Prostaglandin E1-Induced Apnea Prevention in Congenital Heart Disease Neonates: A Randomized Clinical Trial. [PDF]

Crit Care Res Pract
Background: Congenital heart diseases (CHDs) are structural abnormalities of the heart or great vessels. Prostaglandin E1 (PGE1) is used to maintain the ductus arteriosus open in neonates with ductal‐dependent heart lesions but is associated with apnea.
Salamati L, Dehghan B, Sabri MR, Ahmadi A, Ghaderian M, Mahdavi C, Ramezani Nezhad D, Karbasi A, Sedighi M.   +8 more
europepmc   +2 more sources

The effect of topical and intraurethral alprostadil on erectile function: A systematic review and meta‐analysis

Andrology, EarlyView.
Abstract Background Erectile dysfunction (ED) affects up to 50% of men over 40. While phosphodiesterase‐5 inhibitors (PDE5i) are the first line of medical treatment, they are not always effective. Alprostadil, available in injectable, topical, and intraurethral forms, offers an alternative treatment modality.
Iason Papadopoulos, Maksim Tishukov, Ioannis Sokolakis, Ioannis Katafigiotis, Ioannis Leotsakos, Markos Karavitakis, Julian Marcon, Christian G. Stief, Nikolaos Pyrgidis   +8 more
openalex   +2 more sources

The current treatment of erectile dysfunction [PDF]

Journal of Mind and Medical Sciences, 2016
Erectile dysfunction (ED) is the inability to achieve and maintain an erection sufficient for satisfactory sexual intercourse. It is the most frequent sexual dysfunction in elderly men and its prevalence increases with age.
Maria Isabela Sarbu, Mircea Tampa, Mădălina I. Mitran, Cristina I. Mitran, Vasile Benea   +4 more
doaj   +3 more sources

Sexual dysfunction after colorectal and anal cancer-treatment in nurse-led sexological clinics. [PDF]

Colorectal Dis
Abstract Aim Sexual dysfunction after colorectal and anal cancer is common but rarely identified and treated, although effective treatment options do exist. Therefore, we recently established nurse‐led clinics for the treatment of sexual dysfunction after pelvic organ cancer at two Danish university hospitals.
Mikkelsen AH, Thyø A, Seyer-Hansen AD, Drewes AM, Laursen BS, Christensen P, Schwennesen T, Juul T.   +7 more
europepmc   +2 more sources

Combination drug therapy prevents CIAKI by suppressing ER stress-induced apoptosis [PDF]

Scientific Reports
Contrast-induced acute kidney injury (CIAKI) is an important clinical complication that occurs after the application of contrast agent in percutaneous coronary intervention. The pathogenesis of CIAKI is complex.
Xuan Wang, Shan Han, Lili Zhao, Hongliang Cong   +3 more
doaj   +2 more sources

Clinical evaluation of the PowerGlide Pro midline catheter- dwell time, complications and outcomes for various medications including prostaglandins. [PDF]

Langenbecks Arch Surg
Purpose The PowerGlide Pro™ Midline Catheter is a peripheral venous access device with a length of 8–10 cm, allowing the tip to reach far into the venous system. The aim of this study was to evaluate the dwell time of the catheter.
Souri Y, Hernandez Cancino EF, Kerndl H, Hyhlik-Duerr A, Gosslau Y.   +4 more
europepmc   +3 more sources

Influence of alprostadil on the dynamics of blood flow resistance index and renal graft function in the early postoperative period

Трансплантология (Москва), 2022
Aim. To evaluate the effect of continuous intravenous infusion of alprostadil solution on the dynamics of the peripheral resistance to arterial blood flow and renal graft function in the early postoperative period.Material and methods.
P. A. Drozdov, I. V. Nesterenko, D. A. Makeev, O. S. Zhuravel, S. A. Astapovich, D. A. Solomatin, E. A. Lidzhieva   +6 more
doaj   +3 more sources

‘Supported‐at‐Home’ video tuition of the trial dose of intracavernosal alprostadil

BJU International, Volume 134, Issue 5, Page 744-746, November 2024.
Findlay MacAskill, Piotr Śluzar, Patrick Gordon, Karen K. Briggs, Amy Sandher, Tet Yap, Sarah Hewson, Emma Barron, Arun Sahai, Ian Eardley, Majed Shabbir   +10 more
openalex   +2 more sources

Efficacy and Mechanism of Alprostadil in Diabetes Mellitus Combined with Peripheral Atherosclerosis. [PDF]

Anatol J Cardiol
Yin H, Wan Q.
europepmc   +2 more sources

Clinical efficacy of losartan potassium combined with alprostadil in early diabetic nephropathy and its effect on renal function [PDF]

Pak J Med Sci
Gong X, Liu J, Guo H, Zhang W.
europepmc   +2 more sources